Description

Switglim-MV 2/0. 3 Tablet is a combination medicine consisting of two active ingredients, Glimepiride and Metformin. Glimepiride belongs to a class of drugs called sulfonylureas, while Metformin belongs to a class of drugs called biguanides. This tablet is primarily used in the treatment of type 2 diabetes mellitus, which helps to control blood sugar levels effectively. Glimepiride works by stimulating the pancreas to produce more insulin and helps the body use insulin more efficiently. Metformin helps to decrease the production and absorption of glucose from the liver, as well as increases the body’s response to insulin. The synergistic effect of Glimepiride and Metformin helps to improve glycemic control and reduces the risk of complications associated with diabetes. Switglim-MV 2/0. It is important to follow a healthy diet and exercise regularly while using this medication.

Additional information